Vlad Coric

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vlad Coric:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 830,891 $123,387,314 $148.50 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 517,391 $76,832,564 $148.50 03 Oct 2022 By: The Vladimir Coric Marital Trust
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 498,261 $73,991,759 $148.50 03 Oct 2022 By 401(K) Plan
Biohaven Ltd. Chief Executive Officer, Director Common Shares 1,803,968 $17,913,402 $9.93 05 Jan 2026 Direct
Biohaven Ltd. Chief Executive Officer, Director Common Shares 1,195,275 $13,494,654 $11.29 05 Jan 2026 By: The Vlad Coric Family Trust
Biohaven Ltd. Chief Executive Officer, Director Common Shares 740,546 $8,360,764 $11.29 05 Jan 2026 By: The Vladimir Coric Marital Trust
Biohaven Ltd. Chief Executive Officer, Director Common Shares 109,565 $1,236,988 $11.29 05 Jan 2026 By: 401(K) Plan
Royalty Pharma plc Director Class A Ordinary Shares 10,798 $344,996 $31.95 13 May 2025 Direct
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Biohaven Ltd. Chief Executive Officer, Director Stock Options (Right to buy) 343,000 05 Jan 2025 Direct
Biohaven Ltd. Chief Executive Officer, Director Restricted Share Unit Award 28,500 05 Jan 2026 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23,458 01 May 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Common Shares 0 $148.50 03 Oct 2022 By: The Vladimir Coric Family Trust
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Vlad Coric

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BHVN Biohaven Ltd. 05 Jan 2026 3 -$73,780 4 Chief Executive Officer, Director 07 Jan 2026, 21:32
BHVN Biohaven Ltd. 13 Nov 2025 2 +$4,999,995 4 Chief Executive Officer, Director 17 Nov 2025, 07:30
RPRX Royalty Pharma plc 13 May 2025 1 $0 4 Director 14 May 2025, 17:06
RPRX Royalty Pharma plc 21 Apr 2025 1 $0 4 Director 21 Apr 2025, 17:43
RPRX Royalty Pharma plc 07 Apr 2025 0 $0 3/A Director 21 Apr 2025, 17:40
/report/000095017025015343-coric-vlad-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 2 -$21,112 4 Director 06 Feb 2025, 15:49
BHVN Biohaven Ltd. 05 Jan 2025 5 -$262,945 4 Chief Executive Officer, Director 07 Jan 2025, 20:48
BHVN Biohaven Ltd. 02 Oct 2024 1 +$999,970 4 Chief Executive Officer, Director 03 Oct 2024, 07:00
/report/000147929024000085-coric-vlad-2024-05-01 Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:43
BHVN Biohaven Ltd. 22 Apr 2024 1 +$4,999,991 4 Chief Executive Officer, Director 23 Apr 2024, 07:54
BHVN Biohaven Ltd. 05 Apr 2024 3 $0 4 Chief Executive Officer, Director 05 Apr 2024, 20:21
BHVN Biohaven Ltd. 08 Mar 2024 3 $0 4 Chief Executive Officer, Director 08 Mar 2024, 18:35
BHVN Biohaven Ltd. 08 Jan 2024 3 $0 4 Chief Executive Officer, Director 10 Jan 2024, 21:11
BHVN Biohaven Ltd. 02 Jan 2024 1 $0 4 Chief Executive Officer, Director 04 Jan 2024, 20:07
BHVN Biohaven Ltd. 02 Nov 2023 1 $0 4 Chief Executive Officer, Director 06 Nov 2023, 20:34
BHVN Biohaven Ltd. 05 Oct 2023 2 +$9,999,990 4 Chief Executive Officer, Director 10 Oct 2023, 07:17
/report/000147929023000059-coric-vlad-2023-05-03 Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:14
/report/000147929023000033-coric-vlad-2023-03-01 Revance Therapeutics, Inc. 01 Mar 2023 2 $0 4 Director 03 Mar 2023, 15:32
/report/000147929023000032-coric-vlad-2023-03-01 Revance Therapeutics, Inc. 01 Mar 2023 0 $0 3 Director 03 Mar 2023, 15:31
BHVN Biohaven Ltd. 31 Oct 2022 1 +$411,995 4 Chief Executive Officer, Director 01 Nov 2022, 07:34
BHVN Biohaven Ltd. 28 Oct 2022 2 +$2,105,772 4 Chief Executive Officer, Director 31 Oct 2022, 07:52
BHVN Biohaven Ltd. 25 Oct 2022 1 +$8,960,490 4 Chief Executive Officer, Director 26 Oct 2022, 18:22
BHVN Biohaven Ltd. 05 Oct 2022 9 +$5,009,425 4 Chief Executive Officer, Director 06 Oct 2022, 19:20
BHVN Biohaven Ltd. 03 Oct 2022 1 $0 4/A Chief Executive Officer, Director 12 Oct 2022, 18:31
/report/000156218022006963-coric-vlad-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 26 -$137,056,738 4 Chief Executive Officer, Director 03 Oct 2022, 20:26
BHVN Biohaven Ltd. 22 Sep 2022 0 $0 3 Chief Executive Officer, Director 28 Sep 2022, 20:51
/report/000156218022000350-coric-vlad-2022-01-06 Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 8 -$1,322,260 4 Chief Executive Officer, Director 07 Jan 2022, 20:16
/report/000156218022001433-coric-vlad-2021-12-31 Biohaven Pharmaceutical Holding Co Ltd. 31 Dec 2021 4 $0 5 Chief Executive Officer, Director 11 Feb 2022, 20:15
/report/000156218021007299-coric-vlad-2021-11-25 Biohaven Pharmaceutical Holding Co Ltd. 25 Nov 2021 3 -$586,416 4 Chief Executive Officer, Director 26 Nov 2021, 15:28
/report/000120919121043827-coric-vlad-2021-06-29 Social Capital Suvretta Holdings Corp. I 29 Jun 2021 0 $0 3 Director 29 Jun 2021, 20:06